| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.003 | 1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.0042 | 1 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.00094 | 1 |